Winton Group LTD Regenxbio Inc. Transaction History

Winton Group LTD

$1.31 Billion
Q3 2024

A detailed history of Winton Group LTD transactions in Regenxbio Inc. stock. As of the latest transaction made, Winton Group LTD holds 96,936 shares of RGNX stock, worth $738,652. This represents 0.08% of its overall portfolio holdings.

Number of Shares

96,936

Previous 76,840 26.15%

Holding current value

$738,652

Previous $899,000 13.01%

% of portfolio

0.08%

Previous 0.07%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$10.49 - $14.39 $210,807 - $289,181	20,096 Added 26.15%	96,936 $1.02 Million
Q2 2024 Aug 09, 2024	BUY	$11.51 - $21.53 $392,905 - $734,948	34,136 Added 79.94%	76,840 $899,000
Q1 2024 May 14, 2024	BUY	$12.17 - $24.61 $519,707 - $1.05 Million	42,704 New	42,704 $899,000
Q1 2023 May 12, 2023	SELL	$18.08 - $24.55 $539,019 - $731,909	-29,813 Reduced 73.95%	10,503 $198,000
Q4 2022 Feb 14, 2023	BUY	$20.4 - $24.73 $67,564 - $81,905	3,312 Added 8.95%	40,316 $914,000
Q3 2022 Nov 10, 2022	SELL	$22.29 - $35.04 $181,930 - $285,996	-8,162 Reduced 18.07%	37,004 $978,000
Q2 2022 Aug 10, 2022	BUY	$19.35 - $35.04 $599,211 - $1.09 Million	30,967 Added 218.09%	45,166 $1.12 Million
Q1 2022 May 11, 2022	BUY	$24.62 - $34.31 $349,579 - $487,167	14,199 New	14,199 $471,000
Q4 2021 Feb 10, 2022	SELL	$30.19 - $40.28 $361,857 - $482,796	-11,986 Closed	0 $0
Q3 2021 Oct 28, 2021	BUY	$29.09 - $45.68 $348,672 - $547,520	11,986 New	11,986 $502,000
Q3 2020 Oct 30, 2020	SELL	$27.01 - $40.26 $573,692 - $855,122	-21,240 Closed	0 $0
Q2 2020 Aug 05, 2020	SELL	$27.75 - $43.44 $2.12 Million - $3.31 Million	-76,240 Reduced 78.21%	21,240 $782,000
Q1 2020 May 11, 2020	SELL	$21.5 - $54.2 $1.1 Million - $2.78 Million	-51,330 Reduced 34.49%	97,480 $3.16 Million
Q4 2019 Feb 13, 2020	BUY	$34.54 - $44.87 $5.14 Million - $6.68 Million	148,810 New	148,810 $6.1 Million
Q2 2019 Jul 08, 2019	SELL	$42.0 - $59.29 $161,322 - $227,732	-3,841 Closed	0 $0
Q1 2019 May 13, 2019	BUY	$40.82 - $62.45 $156,789 - $239,870	3,841 New	3,841 $220,000
Q4 2018 Feb 05, 2019	SELL	$39.11 - $75.15 $107,200 - $205,986	-2,741 Closed	0 $0
Q3 2018 Nov 02, 2018	BUY	$65.0 - $82.15 $178,165 - $225,173	2,741 New	2,741 $0

Others Institutions Holding RGNX

# of Institutions

196

Shares Held

43M

Call Options Held

104K

Put Options Held

478K

View Full List

About REGENXBIO Inc.

Ticker RGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,230,000
Market Cap $329M
Description
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...

More about RGNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Winton Group LTD with notifications on news.

Account